Strides Pharma Science Ltd Quarterly Result
Strides Pharma Science Ltd
NSE: STAR
Net Profit - Last Quarter
Strides Pharma Science Ltd Quarterly Results Key Highlights
- The revenue of Strides Pharma Science Ltd for the Mar '26 is ₹ 1333 crore as compare to the Dec '25 revenue of ₹ 1301 crore.
- This represent the growth of 2.42% The ebitda of Strides Pharma Science Ltd for the Mar '26 is ₹ 242.88 crore as compare to the Dec '25 ebitda of ₹ 339.48 crore.
- This represent the decline of -28.46% The net profit of Strides Pharma Science Ltd for the Mar '26 is ₹ 129.28 crore as compare to the Dec '25 net profit of ₹ 208.12 crore.
- This represent the decline of -37.88%.
Strides Pharma Science Ltd Quarterly Results Analysis
Market Price of Strides Pharma Science Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 28 Jul 2026 | 1042 |
| 27 Jul 2026 | 1044 |
| 24 Jul 2026 | 1019 |
| 23 Jul 2026 | 1030.6 |
| 22 Jul 2026 | 1040.5 |
| 21 Jul 2026 | 1053.1 |
| 20 Jul 2026 | 1057.95 |
| 17 Jul 2026 | 1077.9 |
| 16 Jul 2026 | 1050.9 |
| 15 Jul 2026 | 1062.3 |
Historical Revenue of Strides Pharma Science Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Strides Pharma Science Ltd
Historical EBITDA of Strides Pharma Science Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Strides Pharma Science Ltd
Historical Net Profit of Strides Pharma Science Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Strides Pharma Science Ltd
Strides Pharma Science Ltd News Hub
Strides Alathur successfully concludes USFDA inspection
Strides Alathur, a wholly owned subsidiary of Strides Pharma Science (Strides) has received an Estab
Read more
19 Aug 24
Strides Pharma arm gets EIR from USFDA for Chennai facility
The good manufacturing practices (GMP) inspection was conducted from 1 April to 5 April 2024. The US
Read more
19 Aug 24
Strides Pharma hits 52-week high after dissolution of US unit
Strides Pharma, as a part of Group entites optimization exercises has liquidated its US unit by the
Read more
16 Aug 24
Strides Pharma Science to hold EGM
Strides Pharma Science announced that an Extra Ordinary General Meeting (EGM) of the Company will be
Read more
09 Aug 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
About Strides Pharma Science Ltd
- Strides Pharma Science Limited was originally incorporated under the name 'Strides Arcolab Limited ' on June 28, 1990.
- In FY 2016, Shasun Pharmaceuticals Limited merged with Strides Arcolab Limited forming a new identity 'Strides Shasun Limited', making it effective from 19 November, 2015 and name of the Company was changed to 'Strides Pharma Science Limited' from 'Strides Shasun Limited' effective on July 18, 2018. Strides Pharma Science is a global pharmaceutical company headquartered in Bengaluru, India.
- The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic.
- It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals.
- Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids.
FAQs for Quarterly Results of Strides Pharma Science Ltd
What key financial metrics are included in Strides Pharma Science Ltd's quarterly results?
When does Strides Pharma Science Ltd announce its quarterly results?
How does Strides Pharma Science Ltd's quarterly performance impact its stock price?
What is the impact of Strides Pharma Science Ltd's quarterly results on dividends?
Are there any special announcements usually made during Strides Pharma Science Ltd's quarterly results?
